775
Views
13
CrossRef citations to date
0
Altmetric
Original article

Efficacy and tolerability of prostaglandin–timolol fixed combinations: an updated systematic review and meta-analysis

, , , &
Pages 1139-1147 | Accepted 01 Apr 2015, Published online: 13 Apr 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Anastasios G. Konstas, Leopold Schmetterer, Vital P. Costa, Gábor Holló, Andreas Katsanos, Philippe Denis, Luciano Quaranta, Murat Irkec, Miguel A. Castejón, Miguel A. Teus & Alan L. Robin. (2020) Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review. Expert Opinion on Drug Safety 19:11, pages 1445-1460.
Read now
Jose M Martinez-de-la-Casa, Shaantanu Donde & Joanna Wierzbowska. (2019) Latanoprost, a balanced prostaglandin. Expert Review of Ophthalmology 14:1, pages 61-72.
Read now
Yasutaka Takagi, Kazunori Santo, Masayo Hashimoto & Takeo Fukuchi. (2018) Ocular hypotensive effects of prostaglandin analogs in Japanese patients with normal-tension glaucoma: a literature review. Clinical Ophthalmology 12, pages 1837-1844.
Read now
Xinghuai Sun, Mingkai Lin, Xuanchu Duan, Chun Zhang & Jian Ming. (2017) Patient satisfaction with fixed-combination bimatoprost/timolol ophthalmic solution: a survey study in patients with glaucoma in China. Patient Preference and Adherence 11, pages 845-852.
Read now

Articles from other publishers (9)

Victoria Toumanidou, Asterios Diafas, Nikolaos Georgiadis & Ioannis Tsinopoulos. (2023) Fixed versus Unfixed Combination of Topical Latanoprost/Timolol for Glaucoma: An Observational Study Investigating the Level of Adherence and Ocular Surface Health. Journal of Clinical Medicine 12:9, pages 3137.
Crossref
Xinghuai Sun, Ke Yao, Qinghuai Liu, Hong Zhang, Xiaoli Xing, Aiwu Fang, Xuanchu Duan, Minbin Yu, Michelle Y. Chen, Jingyuan Yang & Margot L. Goodkin. (2022) Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension. Ophthalmology and Therapy 12:1, pages 341-353.
Crossref
Sonja Jandroković, Sania Vidas Pauk, Dina Lešin Gaćina, Ivan Skegro, Martina Tomić, Sanja Masnec, Tomislav Kuzman & Miro Kalauz. (2022) Tolerability in Glaucoma Patients Switched from Preserved to Preservative-Free Prostaglandin-Timolol Combination: A Prospective Real-Life Study. Clinical Ophthalmology Volume 16, pages 3181-3192.
Crossref
Robert J. Casson. (2022) Medical therapy for glaucoma: A review. Clinical & Experimental Ophthalmology 50:2, pages 198-212.
Crossref
E.V. Karlova & A.V. Zolotarev. (2022) Fixed combination of latanoprost and timolol in the long-term treatment of patients with normal-tension glaucoma. Vestnik oftal'mologii 138:3, pages 82.
Crossref
Makoto Aihara. (2021) Prostanoid receptor agonists for glaucoma treatment. Japanese Journal of Ophthalmology 65:5, pages 581-590.
Crossref
Yi Xing, Lijuan Zhu, Ke Zhang & Shaohua Huang. (2020) The efficacy of the fixed combination of latanoprost and timolol versus other fixed combinations for primary open-angle glaucoma and ocular hypertension: A systematic review and meta-analysis. PLOS ONE 15:2, pages e0229682.
Crossref
N.I. Kurysheva. (2020) Long-term use of latanoprost in the treatment of glaucoma. Vestnik oftal'mologii 136:2, pages 125.
Crossref
Katsuyoshi Suzuki, Naomi Otsuka, Hiroko Hizaki, Masayo Hashimoto & Yasuaki Kuwayama. (2018) Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension. Advances in Therapy 35:6, pages 796-808.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.